Intellectual Property

ARYx aggressively pursues patents and other forms of protection for our technologies, inventions, and improvements. Our pipeline of drug candidates is protected by global filings of patents, both issued and pending, that broadly cover the composition of matter. All drug candidates are classified as new chemical entities (NCEs) and have the same patent protection as any novel pharmaceutical.

ARYx Therapeutics Patents (As of 3.31.10)
Issued or Allowed U.S. Patents 44
Pending U.S. Patent Applications 15
Issued Foreign Patents 114
Pending Foreign Patent Applications 102
TOTAL: 275

Aryx Pipeline

ARYx's goal is to create value by reducing the risk of oral therapies.

Learn More

Partnering with Aryx

We work closely with partners to develop therapies with maximum potential.

Learn More